ABOUT
Motivated by his mother's battle with skin cancer, Dr. Aharon invented the OFIR Scanner (Optical Flow Imaging Reconstruction) and methodology that can detect lesion deformities, a warning sign of skin cancer, and skin abnormalities (Cosmetology). Patented at 2026.
Patternox introduces an innovative handheld OFIR scanner (model name: PatScope) that uses a unique imaging method to detect distortions and irregularities beneath the skin's surface. Unlike conventional methods that rely on visual color changes, often indicators of late-stage conditions, Patternox's solution provides early detection of tissue deformities powered by AI analysis of the lateral Optical Flow under the surface. Patternox offers a non-invasive, accessible device for both diagnostic and cosmetic purposes, marking a significant advancement in proactive skin health monitoring.
Market: Dermatologists, General practitioners (GPs), Beauticians, and Home Users worldwide.
(NAMCS).
Clinical trials: Dr. Barry Galitzer at the SKINCENTER in Florida, USA.
-
Skin cancer detection that relies on color change, which happens at a LATE stage, leads to a high mortality rate.
-
Our solution, PatScope, detects deformities under the skin at an EARLY stage, before they become visible.
-
PatScope is a first award winner, two times.
-
You see, there are about 1.9 billion people with skin deformities. PatScope is designed for use at the point of care by dermatologists, GPs, beauticians, and for home monitoring.
-
It’s already been tested with over 500 lesions at the SKINCENTER in Florida, achieving an impressive first-of-its-kind imaging of skin deformities.
-
Revenue models are Device sales, AI diagnostics, telemedicine, pay-per-use, and reimbursements